United Therapeutics (UTHR) Short-term Investments (2009 - 2026)
United Therapeutics (UTHR) posted Short-term Investments of $874.0 million for Q1 2026, down 35.89% sequentially from $1.4 billion in Q4 2025, and down 38.51% YoY from $1.4 billion in Q1 2025.
United Therapeutics (UTHR) Short-term Investments (2009 - 2026) Analysis & Trends
United Therapeutics has reported Short-term Investments for 18 years, with the latest figure at $874.0 million in Q1 2026.
- Quarterly Short-term Investments fell 38.51% year-over-year to $874.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $874.0 million (down 38.51% YoY) and the FY2025 annual result came in at $1.4 billion, down 13.16% from the prior year.
- Short-term Investments eased to $874.0 million in Q1 2026 per UTHR's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Short-term Investments peaked at $1.9 billion in Q4 2022 and troughed at $874.0 million in Q1 2026.
- A 5-year average of $1.5 billion and a median of $1.6 billion in 2024 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2022 and 2026: Short-term Investments soared 81.24% in 2022, then tumbled 38.51% in 2026.
- Over 5 years, Short-term Investments stood at $1.9 billion in 2022, then fell by 4.85% to $1.8 billion in 2023, then declined by 12.12% to $1.6 billion in 2024, then declined by 13.16% to $1.4 billion in 2025, then plunged by 35.89% to $874.0 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $874.0 million, $1.4 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 859.10 Mn |
| Mar 31, 2026 | 874.00 Mn |
| Dec 31, 2025 | 1.36 Bn |
| Sep 30, 2025 | 1.43 Bn |
| Jun 30, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.42 Bn |
| Dec 31, 2024 | 1.57 Bn |
| Sep 30, 2024 | 1.77 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.46 Bn |
| Dec 31, 2023 | 1.79 Bn |
| Sep 30, 2023 | 1.77 Bn |
| Jun 30, 2023 | 1.61 Bn |
| Mar 31, 2023 | 1.70 Bn |
| Dec 31, 2022 | 1.88 Bn |
| Sep 30, 2022 | 1.65 Bn |
| Jun 30, 2022 | 1.46 Bn |
| Mar 31, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.04 Bn |
| Sep 30, 2021 | 1.09 Bn |